Quest PharmaTech Inc (QPT.V) has had a quiet week with no significant price changes.
This week, Quest PharmaTech Inc's stock remained stable, closing at C$0.02 with no change in price. The company, operating in the health care sector, has seen a lack of major news catalysts recently, leading to a stagnant performance over the past week and month.
Advertisement
Quest PharmaTech Inc
QPT.V
QPT.V
Quest PharmaTech Inc
WealthAwesomeMarket cap
$3.38M
P/E
0.7x
52W high
$0.05
52W low
$0.02
1W change
+0.00%
Beta
-0.31
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on QPT's historical volatility
30-Day Vol
229.7%
Annualized
90-Day Vol
210.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.05 |
| 90 trading days | C$0.02 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should note the limited trading volume and the company's recent financial updates, which may indicate a period of consolidation for Quest PharmaTech.
Quest PharmaTech Inc's stock remains flat at C$0.02.
Despite a recent net income report, the stock has not gained traction in the market.
Bull case
Quest PharmaTech's recent financial statements show a positive net income of C$5.0 million. This improvement suggests there could be potential for growth if this trend continues.
Bear case
The stock's performance has been disappointing, with a significant year-to-date decline of 42.86%. This trend indicates potential challenges ahead for the company.
Price Action
Advertisement
Quest PharmaTech Inc (QPT.V) closed at C$0.02, showing no change in price for the day, week, or month. The stock has experienced a substantial decline of 42.86% year-to-date, indicating ongoing challenges in gaining market traction.
Recent Company News
There has been no significant news this week for Quest PharmaTech Inc. The most recent updates include the company's annual audited financial statements, which reported a net income of C$5.0 million for the year ended January 31, 2026. This was a positive turn compared to the previous year's net loss of C$1.8 million, yet the stock has failed to react positively in the market.
Technical Picture
From a technical standpoint, Quest PharmaTech's stock is currently trading at the lower end of its 52-week range of C$0.02 to C$0.05, representing 0% of its range. The stock is below both its 50-day moving average of C$0.02 and its 200-day moving average of C$0.03, indicating a bearish trend. The beta of -0.31 suggests lower volatility compared to the market, and the recent trading volume of 10,000 shares is significantly below the 20-day average volume of 117,235 shares, reflecting a lack of investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
